July 12, 2021
Counsel for a Daiichi Sankyo subsidiary told a California federal jury during trial openings on Monday that Novartis owes royalties for selling drugs that allegedly infringe its billion-dollar skin cancer treatment patents, while Novartis' attorney countered that his client should pay nothing because the patents are invalid.
July 08, 2021
Attorneys who are vaccinated will be allowed to go maskless before a jury on Monday in a Daiichi Sankyo unit's patent suit in California federal court alleging Novartis is infringing its billion-dollar skin cancer treatment. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.
June 28, 2021
A California federal judge on Friday issued COVID-19 ground rules for an upcoming jury trial on patent infringement claims over a skin cancer treatment, exempting attorneys and witnesses who certify they've been vaccinated from the court's mask mandate.